Biperiden
Akineton (biperiden) is a small molecule pharmaceutical. Biperiden was first approved as Akineton on 1982-01-01. It is used to treat parkinson disease in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M1. In addition, it is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M4, muscarinic acetylcholine receptor M3, and muscarinic acetylcholine receptor M5.
Trade Name | Akineton |
---|---|
Common Name | Biperiden |
Indication | parkinson disease |
Drug Class |